AAPA Archives - CMSC Scholar

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Target Audience The intended audience for this activity is neurologists, neurology nursing professionals, pharmacists, physician assistants, and other health care professionals involved in the management …

Continue reading “Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis”

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration Date: November 30, 2021 Intended Audience: Physicians and their teams providing care for patients with MS (PAs, NPs, nurses, pharmacists) Accompanying this activity are resources to provide evidence-based guidance on necessary laboratory evaluations needed before initiating or switching DMTs, as well as a guide for …

Continue reading “Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights”

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS RELEASE DATE: October 20, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis”

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES RELEASE DATE: October 27, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies”

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES RELEASE DATE: NOVEMEBER 11, 2020 VALID FOR CREDIT THROUGH: OCTOBER 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies”

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: October 1, 2020 EXPIRATION DATE: September 30, 2021 The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis Continuing Education Supplement to the International Journal of MS Care ACKNOWLEDGEMENT This activity is supported by an educational grant from Genentech. TUITION Complimentary GENERAL CME/CNE/CPE INFORMATION In order to successfully complete this continuing education activity, the participant …

Continue reading “The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis”

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September 30, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder TARGET AUDIENCE This activity has been designed to meet …

Continue reading “Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder”

Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies

Release Date: July 8, 2020 Valid for Credit Through: July 31, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies TARGET AUDIENCE This activity has been designed to meet the educational needs of physicians, …

Continue reading “Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies”

A Clinician’s Guide to Cognition in MS

A Clinician’s Guide to Cognition in MSSarah Morrow, MD, MS, FRCPC, FAAN RELEASE DATE: May 29, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, …

Continue reading “A Clinician’s Guide to Cognition in MS”

The Role of Biological Aging In MS Progression

The Role of Biological Aging In MS ProgressionJennifer Graves, MD, PhD, MAS RELEASE DATE: May 29, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, …

Continue reading “The Role of Biological Aging In MS Progression”